Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Bevacizumab (Primary) ; Pemetrexed (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 15 Jan 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record
- 12 Dec 2012 Planned end date changed from 1 Oct 2012 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 12 Dec 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.